Dupont Capital Management’s Myriad Genetics MYGN Stock Holding History

Dupont Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,884	Closed	-$351K	–	1795
2021 Q3	$351K	Sell	10,884 -11,854	-52%	-$394K	0.01%	1025
2021 Q2	$695K	Hold	22,738	–	–	0.02%	797
2021 Q1	$692K	Buy	+22,738	New	+$645K	0.02%	770
2019 Q3	–	Sell	-25,865	Closed	-$719K	–	1244
2019 Q2	$719K	Hold	25,865	–	–	0.02%	640
2019 Q1	$859K	Hold	25,865	–	–	0.02%	592
2018 Q4	$752K	Buy	25,865 +10,863	+72%	+$391K	0.02%	610
2018 Q3	$690K	Hold	15,002	–	–	0.02%	659
2018 Q2	$561K	Buy	15,002 +5,396	+56%	+$182K	0.01%	683
2018 Q1	$284K	Sell	9,606 -22,874	-70%	-$774K	0.01%	774
2017 Q4	$1.12M	Sell	32,480 -14,096	-30%	-$476K	0.03%	496
2017 Q3	$1.69M	Buy	46,576 +16,812	+56%	+$480K	0.04%	404
2017 Q2	$769K	Buy	+29,764	New	+$632K	0.02%	583
2016 Q3	–	Sell	-10,021	Closed	-$307K	–	688
2016 Q2	$307K	Hold	10,021	–	–	0.01%	639
2016 Q1	$375K	Buy	+10,021	New	+$378K	0.01%	576
2014 Q3	–	Sell	-24,330	Closed	-$947K	–	647
2014 Q2	$947K	Sell	24,330 -47,770	-66%	-$1.78M	0.02%	509
2014 Q1	$2.46M	Sell	72,100 -22,855	-24%	-$708K	0.04%	320
2013 Q4	$1.99M	Buy	94,955 +79,155	+501%	+$2M	0.03%	355
2013 Q3	$371K	Buy	+15,800	New	+$449K	0.01%	570

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dupont Capital Management's MYGN Position: Q4 2021 in Review

Dupont Capital Management sold out of Myriad Genetics (MYGN) in Q4 2021, closing a stake of 10,884 shares — an estimated $351K sold.

Dupont Capital Management first reported a position in MYGN in Q3 2013 and held it in 18 quarters. The position peaked at $2.46M in Q1 2014. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2021.

Dupont Capital Management reported no remaining Myriad Genetics position as of Q4 2021 after selling out during the quarter.
Dupont Capital Management sold 10,884 Myriad Genetics shares in Q4 2021, an estimated $351K.
Dupont Capital Management first reported a position in Myriad Genetics in Q3 2013 and held it in 18 quarters.
Dupont Capital Management's Myriad Genetics position peaked at $2.46M in Q1 2014.
197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2021.

Based on Dupont Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.